| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |